摘要
本文对2022年中国临床肿瘤学会《甲状腺髓样癌诊疗指南》外科部分进行解读,旨在为我国临床医师制定相关决策提供科学依据,改善甲状腺髓样癌患者生活质量、提高生存时间。
This article interpreted the surgical chapter in the Guidelines of Chinese Society of Clinical Oncology(CSCO)on Medullary Thyroid Carcinoma,aiming to provide scientific evidence for Chinese clinical physicians to make critical decisions,and improve life quality and survival time for patients with medullary thyroid carcinoma.
作者
王卓颖
Wang Zhuoying(Department of Head and Neck Surgery,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200120,China)
出处
《肿瘤预防与治疗》
2023年第11期927-930,共4页
Journal of Cancer Control And Treatment
关键词
甲状腺髓样癌
指南
手术治疗
转移
Medullary thyroid carcinoma
Guideline
Surgical treatment
Metastasis